Transfusion of convalescent plasma promises mortality benefits in immunocompromised COVID-19 patients
Mayo Clinic: A recent Original Investigation for Infectious Diseases published in JAMA Network Open has mentioned that convalescent plasma is tied to mortality benefits to hospitalised patients with primary or secondary immunosuppression and COVID-19.
Immunocompromised patients have a higher risk for morbidity and mortality associated with COVID-19. They mount antibody responses less frequently to vaccines. To treat COVID-19, neutralizing anti-spike monoclonal-antibody treatment has been used, but evolutions of SARS-CoV-2 have been related to monoclonal antibody-resistant SARS-CoV-2 variants and greater virulence and transmissibility of SARS-CoV-2. COVID-19 convalescent plasma has increased therapeutically based on the presumption that plasma contains antibodies to SARS-CoV-2, which are potentially therapeutic and can be transferred passively to the recipient.
What is the pooled evidence in this context?
Investigating further, a researchers team did a study to assess the growing reports of clinical experiences of COVID-19 immunocompromised patients treated with COVID-19 convalescent plasma transfusion. The lead researcher was Jonathon W.Senefeld, PhD. The study points are:
• The researchers selected relevant RCTs, matched cohort studies, and case reports or series
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.